Lysann Schädlich

A Direct Comparison of Human Papillomavirus Type 16 L1 Particles Reveals a Lower Immunogenicity of Capsomeres than Viruslike Particles with Respect to the Induced Antibody Response

Nadja Thönes, Anna Herreiner, Lysann Schädlich et al. · Journal of Virology · 2008 · 90 citations · Full text

Viral Diagnostics, Immunology, Pathology +20

Refining HPV 16 L1 purification from E. coli: Reducing endotoxin contaminations and their impact on immunogenicity

Lysann Schädlich, Tilo Senger, Carsten J. Kirschning et al. · Vaccine · 2009 · 77 citations

E. Coli, Immunology, Bacteriophage +7

Analysis of Modified Human Papillomavirus Type 16 L1 Capsomeres: the Ability To Assemble into Larger Particles Correlates with Higher Immunogenicity

Lysann Schädlich, Tilo Senger, Britta Gerlach et al. · Journal of Virology · 2009 · 66 citations · Full text

Engineering, Immunology, Pathology +23

Enhanced papillomavirus-like particle production in insect cells

Tilo Senger, Lysann Schädlich, Lutz Gissmann et al. · Virology · 2009 · 57 citations

Viral Replication, Insect Virus, Human Papillomavirus Vaccines +6

Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs

Tilo Senger, Lysann Schädlich, Sonja Textor et al. · Vaccine · 2009 · 25 citations · Full text

Vaccination, Vaccine Development, Human Papillomavirus Vaccines +10